These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16911778)

  • 1. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Landsman A; Tavakkol A
    J Dermatolog Treat; 2007; 18(1):46-52. PubMed ID: 17373090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NailQoL: a quality-of-life instrument for onychomycosis.
    Warshaw EM; Foster JK; Cham PM; Grill JP; Chen SC
    Int J Dermatol; 2007 Dec; 46(12):1279-86. PubMed ID: 18173524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A health-related quality of life measure for use in patients with onychomycosis: a validation study.
    Lubeck DP; Gause D; Schein JR; Prebil LE; Potter LP
    Qual Life Res; 1999; 8(1-2):121-9. PubMed ID: 10457745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
    Piraccini BM; Sisti A; Tosti A
    J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toenail assessment tool for quantitation of visibly infected mycotic nail plate in onychomycosis.
    Tavakkol A; Pollak R; Harkless L; Shebetka KA; Weisfeld M; Kianifard F; Jennings M
    Cutis; 2007 Dec; 80(6):488-94. PubMed ID: 18246881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.
    Szepietowski JC; Reich A; Pacan P; Garlowska E; Baran E;
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):491-6. PubMed ID: 17373976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
    Warrick D; Church L
    J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis.
    Avner S; Nir N; Henri T
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1194-6. PubMed ID: 17062030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.
    Flood EM; Beusterien KM; Green H; Shikiar R; Baran RW; Amonkar MM; Cella D
    Health Qual Life Outcomes; 2006 Jul; 4():42. PubMed ID: 16834773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
    Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
    Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.